The conferees wish to stress their conviction that the strictest adherence to . . . [confidentiality of substance use disorder patient records] is absolutely essential to the success of all drug abuse prevention programs.

we all agree that action must be taken to combat the opioid epidemic ravaging our country, but taking the wrong action because we are not spending the appropriate amount of time to understand the consequences of a proposal could have…

For example, there is simply no excuse for distributors sending more than 13 million doses of opioids to a single pharmacy in a town of just 400 people over a 6-year period.

Taking the wrong action, because we are not spending the appropriate amount of time to understand the consequences of a proposal could have very serious consequences of making things worse.

I think it is a well-intended bill, but I think it is inadequate for the purpose that we need to look at these things more carefully.

I am pleased that we are finally having a hearing to discuss electric vehicles or EVs.

Today's hearing provides a critical opportunity for committee members to better understand 42 CFR Part 2 and the legislative proposal to roll back the heightened protections it provides.

All right. Let me go to McKesson.

The opioid epidemic continues to devastate this country, and virtually no community in America has been left untouched.

Thank you, Mr. Chairman.

This hearing will also help Members hear firsthand why the substance use disorder patient advocacy community is unified in their opposition to rolling back the protections of Part 2.

The opioid epidemic continues to devastate this country, and virtually no community in America has been left untouched.